Healthcare operators in the UAE spend real money acquiring patients: campaigns, referral arrangements, a booking portal, a customer relationship system to manage it all. Almost universally, that spend is measured at the top of the funnel. The reports show enquiries, leads, and bookings, because those are the things the acquisition system can see by itself. The problem is that an enquiry is not value. Value appears only when an acquired patient attends, receives care, is billed, is paid, and comes back. Between the enquiry and that point sit several leaks, and an acquisition system that is not linked to the clinical and billing systems cannot see any of them.
This piece is a perspective on why patient acquisition spend leaks, and why the leak is structurally invisible without clinical and billing linkage. The argument is opinionated. We are not arguing that acquisition spend is wasted, or that marketing does not work. We are arguing that the value of acquisition is only realised at the claim and in retention, not at the enquiry; that the leaks between enquiry and paid, returning care are where the spend is actually lost; and that a customer relationship system not linked to clinical delivery and billing is a lead tracker, not an acquisition system, because it optimises the one number it can see while the numbers that matter sit in systems it does not touch.
The audience for this analysis is operators, growth leads, and owners of UAE clinics and groups who spend on acquisition, report on leads and bookings, and have an uneasy sense that the reported funnel and the actual revenue do not move together. The useful diagnostic question is not "how many leads did the spend produce" but "which sources produced attended, billed, and returning patients, and do we even have the linkage to answer that".
Where the Spend Actually Goes
Below is a simple scenario model of an acquisition funnel. Adjust the inputs to a shape that resembles your own, and watch where the spend is kept and where it leaks. Then toggle between an operation that has clinical and billing linkage and one that does not, to see how much of the funnel is even visible without it. The point is not the specific numbers, which are illustrative; it is that the leaks sit below the line a lead tracker can see, and that the true cost per billed patient is a different and much more useful number than cost per enquiry.
Where acquisition spend is kept and where it leaks
Adjust the inputs, then toggle linkage to see what is visible without it
Why the Leak Is Invisible by Default
The reason the leak is structural rather than a reporting oversight is where the relevant facts live. Whether an acquired patient attended, what care they received, whether that care was billed, whether the claim was paid, and whether they returned are facts that live in the clinical and billing systems, not in the acquisition system. An acquisition system left to itself can only report what it holds, which is the enquiry and perhaps the booking. Everything that converts an enquiry into value happens in other systems, so without linkage the acquisition system is not under-reporting by choice; it is reporting everything it can see, and everything it can see is above the leak.
The funding model makes the stakes concrete. Dubai's health expenditure was around AED 22.24 billion in 2023, with roughly 61 per cent privately financed and approximately 22 per cent paid out of pocket. In a predominantly private market, acquisition is a real commercial investment and its return is realised specifically at the billed, paid encounter and in the returning relationship, both of which are private-pay or insured events recorded outside the acquisition system. The more privately financed the market, the more the value of acquisition concentrates exactly in the part of the funnel a lead tracker cannot see.
Competition sharpens it further. With 5,372 licensed health facilities in Dubai in 2024, patients have alternatives at every step, and the sources that produce the most enquiries are frequently not the sources that produce the patients who attend, get billed, and return. An operator optimising on enquiries is optimising on the cheapest signal, not the valuable one, and may be moving spend toward sources that look efficient at the top of the funnel and are poor at producing paid, returning care. Without linkage, that mistake is not just possible; it is the default behaviour the available data encourages.
The shift in one observation
An acquisition system measures the enquiry because the enquiry is the only thing it holds. The value, the billed encounter and the returning patient, is held in the clinical and billing systems. Without linkage between them, the operation optimises the number it can see and is blind to the numbers that pay for the spend. The leak is not hidden by carelessness; it is hidden by the boundary between systems, and only linkage across that boundary makes it visible.
Where the Spend Leaks
The unlinked model loses acquisition value in four predictable places.
Enquiries that never convert
Enquiries that do not become bookings are counted as success by a lead tracker because the enquiry is the metric. The spend that produced them is recorded as working when it produced nothing billable. The operation cannot tell a productive source from an enquiry-generating one because it never sees past the enquiry.
Bookings that do not attend
The gap between a booking and an attendance is pure acquisition leak: money was spent, intent was captured, and no care happened. Without linkage to the clinical schedule, the acquisition system records the booking as a win and never learns it did not convert into a patient in a chair.
Care delivered but not billed
An attended patient whose care does not convert cleanly into a paid claim is the most expensive leak, because the operation incurred both the acquisition cost and the cost of delivering care, and recovered neither. A lead tracker cannot see this at all; it is two systems away from the enquiry it is reporting on.
One visit, never recalled
Acquisition economics only work if the cost is amortised over a relationship, not a single visit. A patient who attends once and is never recalled makes the acquisition permanently expensive. Retention is a clinical and billing fact; an unlinked acquisition system cannot measure it and so cannot manage the lever that makes the spend pay.
The Numbers
Two Ways to Run Acquisition
The difference between operators whose acquisition spend compounds and those whose leaks is whether the acquisition system is linked to clinical delivery and billing.
| Dimension | Lead tracker only | Linked acquisition system |
|---|---|---|
| What is measured | Enquiries and bookings, the top of the funnel. | Attended, billed, paid, and returning patients by source. |
| Cost metric | Cost per enquiry, the cheapest and least useful signal. | Cost per billed, returning patient, the signal that matters. |
| Source decisions | Spend moved toward enquiry-rich sources. | Spend moved toward sources that produce paid, returning care. |
| No-shows and unbilled care | Invisible. Counted as success upstream. | Visible as the leak they are, and actionable. |
| Retention | Unmeasured. The amortising lever is unmanaged. | Measured and managed, so acquisition cost is amortised. |
Acquisition spend does not leak because marketing is bad. It leaks because the value of acquisition is realised in the clinical and billing systems, and a customer system that is not linked to them optimises the one number it can see while the numbers that pay for the spend stay in systems it never touches.
What a Linked Acquisition System Looks Like
The pattern in operators whose acquisition spend compounds is recognisable. The acquisition source is carried through to the clinical encounter and the claim, so the operation can say not just which source produced an enquiry but which produced an attended, billed, paid, and returning patient. Cost is measured per billed, returning patient rather than per enquiry, so spend decisions are made on the signal that matters. No-shows and unbilled attended care are visible as acquisition leak rather than disappearing between systems. Retention is measured and managed as part of the same picture, because it is the lever that makes the original spend pay. The operation moves money toward what produces paid, returning care, which is frequently not what produces the most enquiries.
This does not necessarily mean replacing the customer, clinical, or billing systems already in place. In many operations the linkage can be built between existing systems, carrying the acquisition source through to the encounter and the claim. Replacement becomes the better option mainly where the existing systems cannot pass that linkage at all. Which applies is specific to the systems in place, and is established in scoping before any build commitment.
How This Sits Alongside the Operator's Own Operations
The configuration keeps a clear separation. The healthcare operator delivers the clinical care, owns its payer and patient relationships, makes every clinical and commercial decision, and is responsible for its own marketing conduct and data-protection obligations. The software is the instrumentation: the linkage that carries acquisition source through to the encounter and the claim, and the measurement of true cost and retention.
This is the role BY BANKS is positioned for. We are an independent software engineering company based in the UAE. We design and build software and hand it over to the operator who runs it. We do not run marketing, we do not make clinical or commercial determinations, we are not a regulated healthcare entity, and we are not affiliated with any authority. The operator owns the care, the patient relationships, the commercial decisions, and its own marketing and data-protection compliance; we build the system that lets acquisition be measured against paid, returning care rather than enquiries. The accountable party leads and owns the obligations; we build to their direction.
Where This Analysis Is Useful
The conversations where this perspective is most useful tend to be at three moments: an operator whose reported funnel looks healthy while revenue does not move with it; a group that cannot say which acquisition sources produce paid, returning patients rather than enquiries; or an owner reviewing acquisition spend and realising cost per enquiry is the only number available and it is not the number that matters. The honest answer is usually the same: the spend leaks below the line a lead tracker can see, and only linkage to clinical delivery and billing makes the part that pays visible.
For broader related work, see our perspective on why claims in Dubai are decided at the point of care and our perspective on the cost of running a Dubai clinic group on single-site systems. The applied work sits across our healthcare CRM software and patient management software capabilities, within the broader healthcare software practice and our operational platforms work. Get in touch if a 45-minute conversation about a specific acquisition picture would be useful.
Frequently Asked Questions
No. We are an independent software engineering company based in the UAE. We design and build software and hand it over to the operator who runs it. We do not run marketing or acquisition campaigns, we do not make clinical or commercial determinations, and we are not a regulated healthcare entity. On any engagement, the operator owns the care, the patient relationships, the commercial decisions, and its own marketing and data-protection compliance. We build the system that links acquisition to paid, returning care; the operator runs the acquisition and owns the decisions.
No. The calculator is a reasoning tool. Every figure in it is an input or an illustrative composite, not a benchmark, a measured result, or any claim of outcomes from BY BANKS or any operator. Its only purpose is to show how funnel structure and linkage change what is visible. Your own figures, drawn from your own systems, are the only meaningful ones, and producing them reliably is itself part of what linkage enables.
It can, and those questions are the operator's to answer against the applicable rules, with qualified advice where needed. Linkage has to be designed with data-protection obligations in mind, and the operator remains responsible for lawful processing, consent where required, and the governance of patient data. We build to the operator's data-protection requirements and design for least-exposure linkage; we do not make the data-protection determinations or assume the operator's compliance responsibility.
Often not. In many operations the linkage can be built between the systems already in place, carrying the acquisition source through to the encounter and the claim. Replacement becomes the better option mainly where the existing systems structurally cannot pass that linkage. Which applies is specific to the systems in place and is established in scoping before any build commitment.
It is sequenced and does not require pausing acquisition. The usual starting point is to carry the acquisition source through to the billed encounter for the highest-spend channels, so true cost per billed patient becomes visible where the money is largest. No-show and unbilled-care visibility follows, then retention measurement, which is the lever that amortises the spend. The order is driven by where the spend is largest and the visibility weakest, which scoping establishes for the specific operation.
Patient acquisition spend is widely judged on enquiries and bookings because those are the only things an acquisition system holds by itself. Its value, though, is realised at the billed, paid encounter and in the returning relationship, both recorded in the clinical and billing systems. Without linkage across that boundary the operation optimises the cheap signal and is blind to the expensive leaks, and in a predominantly private market that blindness is exactly where the money goes. The operators whose spend compounds are the ones who linked acquisition to paid, returning care and moved spend toward what produces it. The build is software work; the care, the commercial decisions, and the marketing and data-protection responsibilities remain entirely the operator's, and the system simply makes the part of the funnel that pays for the spend visible.
References to the Dubai healthcare funding model and provider market are descriptive of publicly available information. The funding and facility figures cited (Dubai health expenditure of approximately AED 22.24 billion in 2023, around 61% privately financed, approximately 22% out of pocket, and 5,372 licensed Dubai health facilities in 2024) are drawn from public sources listed on our Sources and Data page; the calculator and all funnel figures are illustrative scenario inputs, not benchmarks, measured results, or claims of outcomes for BY BANKS or any operator. BY BANKS is an independent software engineering company; we do not run marketing, we do not make clinical or commercial determinations, and we are not a regulated healthcare entity or affiliated with any authority. On any healthcare engagement, the operator owns the care, the patient relationships, the commercial decisions, and responsibility for its own marketing conduct and data-protection compliance. This article is not marketing, commercial, data-protection, or legal advice; operators should obtain qualified advice for their specific obligations. Public sources used in this piece are listed on our Sources and Data page.
Ready to Build Something?
If this resonated, let's talk about how we can apply these ideas to your business.
Start a Conversation